Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2002 Oct;110(Suppl 5):851–854. doi: 10.1289/ehp.02110s5851

Silent latency periods in methylmercury poisoning and in neurodegenerative disease.

Bernard Weiss 1, Thomas W Clarkson 1, William Simon 1
PMCID: PMC1241259  PMID: 12426145

Abstract

This article discusses three examples of delay (latency) in the appearance of signs and symptoms of poisoning after exposure to methylmercury. First, a case is presented of a 150-day delay period before the clinical manifestations of brain damage after a single brief (<1 day) exposure to dimethylmercury. The second example is taken from the Iraq outbreak of methylmercury poisoning in which the victims consumed contaminated bread for several weeks without any ill effects. Indeed, signs of poisoning did not appear until weeks or months after exposure stopped. The last example is drawn from observations on nonhuman primates and from the sequelae of the Minamata, Japan, outbreak in which low chronic doses of methylmercury may not have produced observable behavioral effects for periods of time measured in years. The mechanisms of these latency periods are discussed for both acute and chronic exposures. Parallels are drawn with other diseases that affect the central nervous system, such as Parkinson disease and post-polio syndrome, that also reflect the delayed appearance of central nervous system damage.

Full Text

The Full Text of this article is available as a PDF (141.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakir F., Damluji S. F., Amin-Zaki L., Murtadha M., Khalidi A., al-Rawi N. Y., Tikriti S., Dahahir H. I., Clarkson T. W., Smith J. C. Methylmercury poisoning in Iraq. Science. 1973 Jul 20;181(4096):230–241. doi: 10.1126/science.181.4096.230. [DOI] [PubMed] [Google Scholar]
  2. Calabrese E. J., Baldwin L. A. U-shaped dose-responses in biology, toxicology, and public health. Annu Rev Public Health. 2001;22:15–33. doi: 10.1146/annurev.publhealth.22.1.15. [DOI] [PubMed] [Google Scholar]
  3. Calne D. B., Eisen A., McGeer E., Spencer P. Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment? Lancet. 1986 Nov 8;2(8515):1067–1070. doi: 10.1016/s0140-6736(86)90469-1. [DOI] [PubMed] [Google Scholar]
  4. Cernichiari E., Toribara T. Y., Liang L., Marsh D. O., Berlin M. W., Myers G. J., Cox C., Shamlaye C. F., Choisy O., Davidson P. The biological monitoring of mercury in the Seychelles study. Neurotoxicology. 1995 Winter;16(4):613–628. [PubMed] [Google Scholar]
  5. Clarkson T. W. Environmental contaminants in the food chain. Am J Clin Nutr. 1995 Mar;61(3 Suppl):682S–686S. doi: 10.1093/ajcn/61.3.682S. [DOI] [PubMed] [Google Scholar]
  6. Cory-Slechta D. A., Weiss B., Cox C. Delayed behavioral toxicity of lead with increasing exposure concentration. Toxicol Appl Pharmacol. 1983 Dec;71(3):342–352. doi: 10.1016/0041-008x(83)90021-2. [DOI] [PubMed] [Google Scholar]
  7. Evans H. L., Garman R. H., Weiss B. Methylmercury: exposure duration and regional distribution as determinants of neurotoxicity in nonhuman primates. Toxicol Appl Pharmacol. 1977 Jul;41(1):15–33. doi: 10.1016/0041-008x(77)90051-5. [DOI] [PubMed] [Google Scholar]
  8. Magos L., Brown A. W., Sparrow S., Bailey E., Snowden R. T., Skipp W. R. The comparative toxicology of ethyl- and methylmercury. Arch Toxicol. 1985 Sep;57(4):260–267. doi: 10.1007/BF00324789. [DOI] [PubMed] [Google Scholar]
  9. Martyn C. N., Barker D. J., Osmond C. Motoneuron disease and past poliomyelitis in England and Wales. Lancet. 1988 Jun 11;1(8598):1319–1322. doi: 10.1016/s0140-6736(88)92129-0. [DOI] [PubMed] [Google Scholar]
  10. Miura K., Clarkson T. W., Ikeda K., Naganuma A., Imura N. Establishment and characterization of methylmercury-resistant PC12 cell line. Environ Health Perspect. 1994 Sep;102 (Suppl 3):313–315. doi: 10.1289/ehp.94102s3313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nierenberg D. W., Nordgren R. E., Chang M. B., Siegler R. W., Blayney M. B., Hochberg F., Toribara T. Y., Cernichiari E., Clarkson T. Delayed cerebellar disease and death after accidental exposure to dimethylmercury. N Engl J Med. 1998 Jun 4;338(23):1672–1676. doi: 10.1056/NEJM199806043382305. [DOI] [PubMed] [Google Scholar]
  12. Rice D. C. Evidence for delayed neurotoxicity produced by methylmercury. Neurotoxicology. 1996 Fall-Winter;17(3-4):583–596. [PubMed] [Google Scholar]
  13. Thompson S. A., White C. C., Krejsa C. M., Diaz D., Woods J. S., Eaton D. L., Kavanagh T. J. Induction of glutamate-cysteine ligase (gamma-glutamylcysteine synthetase) in the brains of adult female mice subchronically exposed to methylmercury. Toxicol Lett. 1999 Oct 29;110(1-2):1–9. doi: 10.1016/s0378-4274(99)00133-2. [DOI] [PubMed] [Google Scholar]
  14. Vahter M., Mottet N. K., Friberg L., Lind B., Shen D. D., Burbacher T. Speciation of mercury in the primate blood and brain following long-term exposure to methyl mercury. Toxicol Appl Pharmacol. 1994 Feb;124(2):221–229. doi: 10.1006/taap.1994.1026. [DOI] [PubMed] [Google Scholar]
  15. Zigmond M. J., Abercrombie E. D., Berger T. W., Grace A. A., Stricker E. M. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci. 1990 Jul;13(7):290–296. doi: 10.1016/0166-2236(90)90112-n. [DOI] [PubMed] [Google Scholar]
  16. vom Saal F. S., Timms B. G., Montano M. M., Palanza P., Thayer K. A., Nagel S. C., Dhar M. D., Ganjam V. K., Parmigiani S., Welshons W. V. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):2056–2061. doi: 10.1073/pnas.94.5.2056. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES